Specificity of kidney-bound antibodies in Goodpasteure's syndrome

R. Saxena, P. Bygren, R. Butkowski, J. Wieslander

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The specificity of kidney-bound antibodies in Goodpasture's syndrome was studied and compared with the specificity of circulating anti-glomerular basement membrane (GBM) antibodies. Antibodies were eluted from kidneys of two patients with Goodpasture's syndrome and from one normal human kidney. Their specificity was studied by indirect immunofluorescence microscopy, ELISA and immunoblotting using purified GBM components as antigens. It was shown that the reactivity of the eluted antibodies was very similar to those of the circulating anti-GBM antibodies. Both showed major reactivity against the M2 subunit of the globular domain of collagen IV. Competitive inhibition of the binding of 125I-labelled serum antibodies from a patient with Goodpasture's syndrome to the Goodpasture antigen by the eluted antibodies and those from their respective sera further supported that the circulating and the kidney-bound anti-GBM antibodies have similar specificity. These observations extend the support to the clinical usage of plasmapheresis and more recently, immunoadsorption using a staphylococcal protein A as the effective therapeutic measure for the removal of circulating anti-GBM antibodies in the management of Goodpasture's syndrome.

Original languageEnglish (US)
Pages (from-to)31-36
Number of pages6
JournalClinical and Experimental Immunology
Volume78
Issue number1
StatePublished - 1989

Fingerprint

Glomerular Basement Membrane
Kidney
Anti-Glomerular Basement Membrane Disease
Antibodies
Competitive Binding
Plasmapheresis
Staphylococcal Protein A
Indirect Fluorescent Antibody Technique
Serum
Fluorescence Microscopy
Immunoblotting
Collagen
Enzyme-Linked Immunosorbent Assay
Antigens

ASJC Scopus subject areas

  • Immunology

Cite this

Specificity of kidney-bound antibodies in Goodpasteure's syndrome. / Saxena, R.; Bygren, P.; Butkowski, R.; Wieslander, J.

In: Clinical and Experimental Immunology, Vol. 78, No. 1, 1989, p. 31-36.

Research output: Contribution to journalArticle

Saxena, R, Bygren, P, Butkowski, R & Wieslander, J 1989, 'Specificity of kidney-bound antibodies in Goodpasteure's syndrome', Clinical and Experimental Immunology, vol. 78, no. 1, pp. 31-36.
Saxena, R. ; Bygren, P. ; Butkowski, R. ; Wieslander, J. / Specificity of kidney-bound antibodies in Goodpasteure's syndrome. In: Clinical and Experimental Immunology. 1989 ; Vol. 78, No. 1. pp. 31-36.
@article{ee8f7d334c2c467284ad407c5e64160f,
title = "Specificity of kidney-bound antibodies in Goodpasteure's syndrome",
abstract = "The specificity of kidney-bound antibodies in Goodpasture's syndrome was studied and compared with the specificity of circulating anti-glomerular basement membrane (GBM) antibodies. Antibodies were eluted from kidneys of two patients with Goodpasture's syndrome and from one normal human kidney. Their specificity was studied by indirect immunofluorescence microscopy, ELISA and immunoblotting using purified GBM components as antigens. It was shown that the reactivity of the eluted antibodies was very similar to those of the circulating anti-GBM antibodies. Both showed major reactivity against the M2 subunit of the globular domain of collagen IV. Competitive inhibition of the binding of 125I-labelled serum antibodies from a patient with Goodpasture's syndrome to the Goodpasture antigen by the eluted antibodies and those from their respective sera further supported that the circulating and the kidney-bound anti-GBM antibodies have similar specificity. These observations extend the support to the clinical usage of plasmapheresis and more recently, immunoadsorption using a staphylococcal protein A as the effective therapeutic measure for the removal of circulating anti-GBM antibodies in the management of Goodpasture's syndrome.",
author = "R. Saxena and P. Bygren and R. Butkowski and J. Wieslander",
year = "1989",
language = "English (US)",
volume = "78",
pages = "31--36",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Specificity of kidney-bound antibodies in Goodpasteure's syndrome

AU - Saxena, R.

AU - Bygren, P.

AU - Butkowski, R.

AU - Wieslander, J.

PY - 1989

Y1 - 1989

N2 - The specificity of kidney-bound antibodies in Goodpasture's syndrome was studied and compared with the specificity of circulating anti-glomerular basement membrane (GBM) antibodies. Antibodies were eluted from kidneys of two patients with Goodpasture's syndrome and from one normal human kidney. Their specificity was studied by indirect immunofluorescence microscopy, ELISA and immunoblotting using purified GBM components as antigens. It was shown that the reactivity of the eluted antibodies was very similar to those of the circulating anti-GBM antibodies. Both showed major reactivity against the M2 subunit of the globular domain of collagen IV. Competitive inhibition of the binding of 125I-labelled serum antibodies from a patient with Goodpasture's syndrome to the Goodpasture antigen by the eluted antibodies and those from their respective sera further supported that the circulating and the kidney-bound anti-GBM antibodies have similar specificity. These observations extend the support to the clinical usage of plasmapheresis and more recently, immunoadsorption using a staphylococcal protein A as the effective therapeutic measure for the removal of circulating anti-GBM antibodies in the management of Goodpasture's syndrome.

AB - The specificity of kidney-bound antibodies in Goodpasture's syndrome was studied and compared with the specificity of circulating anti-glomerular basement membrane (GBM) antibodies. Antibodies were eluted from kidneys of two patients with Goodpasture's syndrome and from one normal human kidney. Their specificity was studied by indirect immunofluorescence microscopy, ELISA and immunoblotting using purified GBM components as antigens. It was shown that the reactivity of the eluted antibodies was very similar to those of the circulating anti-GBM antibodies. Both showed major reactivity against the M2 subunit of the globular domain of collagen IV. Competitive inhibition of the binding of 125I-labelled serum antibodies from a patient with Goodpasture's syndrome to the Goodpasture antigen by the eluted antibodies and those from their respective sera further supported that the circulating and the kidney-bound anti-GBM antibodies have similar specificity. These observations extend the support to the clinical usage of plasmapheresis and more recently, immunoadsorption using a staphylococcal protein A as the effective therapeutic measure for the removal of circulating anti-GBM antibodies in the management of Goodpasture's syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0024394349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024394349&partnerID=8YFLogxK

M3 - Article

VL - 78

SP - 31

EP - 36

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 1

ER -